Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Day One to acquire Mersana Therapeutics for up to $285 million
-
Day One to Acquire Mersana Therapeutics to Advance Mission to Bring New Medicines to People of All Ages with Life-Threatening Diseases
-
TD Cowen on Day One Biopharmaceuticals (DAWN): 'Focused Approach Could Lead to Double-Digit Growth'
-
Day One Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Progress
-
Day One Biopharmaceuticals (DAWN) Announces 10.55M Share Offering at $14.50/sh
-
Day One Announces Oversubscribed $175.0 Million Private Placement
-
TD Cowen Reiterates Buy Rating on Day One Biopharmaceuticals (DAWN)
-
Day One Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Progress
-
Day One Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Day One Biopharmaceuticals (DAWN) Prices 11.54M Share Offering at $13/sh
-
Day One Announces Pricing of Public Offering of Common Stock
-
Day One (DAWN) Announces Proposed $150M Public Offering of Common Stock
-
Day One Announces Proposed Public Offering of Common Stock
-
Day One Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Progress
-
Day One Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Progress
-
Day One to Participate in the Cowen 43rd Annual Health Care Conference
-
Day One to Participate in the Cowen 43rd Annual Health Care Conference
-
Day One Biopharmaceuticals (DAWN) Named Best 2023 Stock Idea at Cowen
-
Day One Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Day One Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Day One Biopharmaceuticals (DAWN) Prices 10M Share Offering at $15
-
Day One Announces Pricing of Upsized Public Offering of Common Stock
-
Day One Announces Pricing of Upsized Public Offering of Common Stock
-
Day One Biopharmaceuticals (DAWN) Announces $125M Proposed Public Offering of Common Stock
-
Day One Announces Proposed Public Offering of Common Stock
-
Day One Announces Proposed Public Offering of Common Stock
-
Day One Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Progress
-
Day One Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Progress
-
Day One to Participate in the Cowen 42nd Annual Health Care Conference
-
Day One to Participate in the Cowen 42nd Annual Health Care Conference
-
Cowen Starts Day One Biopharmaceuticals (DAWN) at Outperform
-
Day One Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Day One Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Day One Biopharmaceuticals (DAWN) IPO Opens 56% Higher
-
Day One Biopharmaceuticals (DAWN) Prices 10M Share Upsized IPO at $16/Sh
-
Day One Announces Pricing of Upsized Initial Public Offering
-
Day One Announces Pricing of Upsized Initial Public Offering

